Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Hoy, Andrew R ^a,b,c,d   Ly, Martina ^b,e,f   Carlsson, Cynthia M ^b,e   Okonkwo, Ozioma C ^b,e   Zetterberg, Henrik ^g,h   Blennow, Kaj ^g   Sager, Mark A ^b   Asthana, Sanjay ^b,e   Johnson, Sterling C ^b,e   Alexander, Andrew L ^b,c   Bendlin, Barbara B ^b,e  

^a Medical Service Corps   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL NEUROIMAGING; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYELINATED NERVE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PRECLINICAL STUDY; REY AUDITORY VERBAL LEARNING TEST; RISK ASSESSMENT; TRACTOGRAPHY; VOXEL BASED MORPHOMETRY; WHITE MATTER; WISCONSIN; AGED; PATHOLOGY; PROCEDURES;

AGED; ALZHEIMER DISEASE; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; WHITE MATTER;

EID: 85015237237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0173982     Document Type: Article

References (88)

1. Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997; 41:17-24. https://doi. org/10.1002/ana.410410106 PMID: 9005861
2. Lassmann H, Fischer P, Jellinger K. Synaptic pathology of Alzheimer's disease. Annals of the New York Academy of Sciences. 1993. p. 59-64.
3. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol. 1990; 27:457-64. https://doi.org/10.1002/ana.410270502 PMID: 2360787
4. Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, et al. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Brain. 2013; 136:2510-26. https:// doi.org/10.1093/brain/awt171 PMID: 23824488
5. Andrade-Moraes CH, Oliveira-Pinto A V, Castro-Fonseca E, da Silva CG, Guimarães DM, Szczupak D, et al. Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles. Brain [Internet]. 2013; 136(Pt 12):3738-52. https://doi.org/10.1093/brain/awt273 PMID: 24136825
6. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed [Internet]. 2002 [cited 2013 Sep 20]; 15(7-8):435-55. https://doi.org/10.1002/nbm.782 PMID: 12489094
7. Pfefferbaum A, Sullivan E V., Hedehus M, Lim KO, Adalsteinsson E, Moseley M. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med. 2000; 44:259-68. PMID: 10918325
8. Masliah E, Mallory M, Hansen L, DeTeresa R, Terry RD. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology. 1993; 43:192-7. PMID: 8423884
9. Ly M, Canu E, Xu G, Oh J, Mclaren DG, Dowling NM, et al. Midlife measurements of white matter microstructure predict subsequent regional white matter atrophy in healthy adults. Hum Brain Mapp. 2014; 35:2044-54. https://doi.org/10.1002/hbm.22311 PMID: 23861348
10. Bendlin BB, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Willette A a, et al. CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One [Internet]. 2012 Jan [cited 2014 Nov 6]; 7(6):e37720. https://doi.org/10.1371/journal.pone.0037720 PMID: 22701578
11. Hanyu H, Asano T, Sakurai H, Imon Y, Iwamoto T, Takasaki M, et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. J Neurol Sci. 1999; 167:37-44. PMID: 10500260
12. Canu E, McLaren DG, Fitzgerald ME, Bendlin BB, Zoccatelli G, Alessandrini F, et al. Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease. J Alzheimer's Dis. 2010; 19:963-76.
13. Pasternak O, Westin C-F, Bouix S, Seidman LJ, Goldstein JM, Woo T-UW, et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci [Internet]. 2012 Nov 28 [cited 2013 Oct 3]; 32(48):17365-72. https://doi.org/10.1523/JNEUROSCI.2904-12.2012 PMID: 23197727
14. Alexander AL, Hasan KM, Lazar M, Tsuruda JS, Parker DL. Analysis of Partial Volume Effects in Diffusion-Tensor MRI. 2001; 780:770-80.
15. Metzler-Baddeley C, O'Sullivan MJ, Bells S, Pasternak O, Jones DK. How and how not to correct for CSF-contamination in diffusion MRI. Neuroimage [Internet]. Elsevier Inc.; 2012 Jan 16 [cited 2013 Oct 19]; 59(2):1394-403. https://doi.org/10.1016/j.neuroimage.2011.08.043 PMID: 21924365
16. Pasternak O, Shenton ME, Westin C-F. Estimation of extracellular volume from regularized multi-shell diffusion MRI. Med Image Comput Comput Assist Interv [Internet]. 2012 Jan; 15(Pt 2):305-12. PMID: 23286062
17. Rathi Y, Pasternak O, Savadjiev P, Michailovich O, Bouix S, Kubicki M, et al. Gray matter alterations in early aging: A diffusion magnetic resonance imaging study. Hum Brain Mapp [Internet]. 2013 Dec 31 [cited 2014 Jan 10];00.
18. Tosto G, Zimmerman ME, Carmichael OT, Brickman AM. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol [Internet]. 2014; 71:872-7. https://doi.org/10.1001/jamaneurol.2014.667 PMID: 24821476
19. Brinkmalm G, Brinkmalm A, Bourgeois P, Persson R, Hansson O, Portelius E, et al. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease. Brain Res [Internet]. 2013 Jun 4 [cited 2014 Nov 30]; 1513:117-26. https://doi.org/10.1016/j.brainres.2013.03.019 PMID: 23541617
20. Sager MA, Hermann B, La Rue A. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. J Geriatr Psychiatry Neurol. 2005; 18:245-9. https://doi.org/10.1177/0891988705281882 PMID: 16306248
21. Roses AD, Saunders AM. APOE is a major susceptibility gene for Alzheimer's disease. Curr Opin Biotechnol. 1994; 5(6):663-7. PMID: 7765750
22. Wu YC, Alexander AL. Hybrid diffusion imaging. Neuroimage. 2007; 36:617-29. https://doi.org/10. 1016/j.neuroimage.2007.02.050 PMID: 17481920
23. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009; 302(4):385-93. https://doi.org/10.1001/jama.2009.1064 PMID: 19622817
24. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta;42 in humans. Ann Neurol. 2006; 59(3):512-9. https://doi.org/10.1002/ana.20730 PMID: 16372280
25. Buerger K, Ewers M, Pirttil T, Zinkowski R, Alafuzoff I, Teipel SJet al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain. 2006; 129(11):3035-41.
26. Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, Trojanowski JQ. Total and phosphorylated tau protein as biological markers of Alzheimer's disease. Experimental Gerontology. 2010. p. 30-40.
27. Lewczuk P, Esselmann H, Bibl M, Beck G, Maler JM, Otto M, et al. Tau protein phosphorylated at threonine181 in CSF as a neurochemical biomarker in Alzheimer's disease. J Mol Neurosci. 2004; 23(1-2):115-22. https://doi.org/10.1385/JMN:23:1-2:115 PMID: 15126697
28. Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P. Neurochem Int. 2009; 55(4):214-8. https://doi.org/10.1016/j.neuint.2009.02.017 PMID: 19524111
29. Sämgård K, Zetterberg H, Blennow K, Hansson O, Minthon L, Londos E. Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity. Int J Geriatr Psychiatry. 2010; 25(4):403-10. https://doi.org/ 10.1002/gps.2353 PMID: 19650161
30. Zetterberg H, Skillback T, Mattsson N, Trojanowski JQ, Portelius E, Shaw LM, et al. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. JAMA Neurol. 2015; 73(1):1-8.
31. Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, Mnsson JE, et al. Cerebrospinal fluid microglial markers in Alzheimer's disease: Elevated chitotriosidase activity but lack of diagnostic utility. NeuroMolecular Med. 2011; 13(2):151-9. https://doi.org/10.1007/s12017-011-8147-9 PMID: 21567187
32. Perneczky R, Tsolakidou A, Arnold A, Diehl-Schmid J, Grimmer T, Frstl H, et al. CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease. Neurology. 2011; 77(1):35-8. https:// doi.org/10.1212/WNL.0b013e318221ad47 PMID: 21700579
33. Kawas C, Segal J, Stewart WF, Corrada M, Thal LJ. A validation study of the Dementia Questionnaire. Arch Neurol. 1994; 51:901-6. PMID: 8080390
34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul; 34(7):939-44. PMID: 6610841
35. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011 May; 7(3):263-9.
36. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the state of patients for the clinician. J Psychiatr Res. 1975; 12:189-98. PMID: 1202204
37. Strauss EH, Sherman EMS, Spreen O. A compendium of neuropsychological tests: Adminsitration, norms, and commentary (2nd ed.). Administration Norms And Commentary. 1998.
38. Cox SG. Neuropsychological assessment (4th edn). Br J Clin Psychol. 2005; 44:454.
39. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery and REHABIT: A model for integrating evaluation and remediation of cognitive impairment. Cogn Rehabil. 1988; 6:10-7.
40. Hoy AR, Koay CG, Kecskemeti SR, Alexander AL. Optimization of a Free Water Elimination Two-Compartment Model for Diffusion Tensor Imaging. Neuroimage [Internet]. Elsevier B.V.; 2014 Sep [cited 2014 Sep 29]; 103:323-33. https://doi.org/10.1016/j.neuroimage.2014.09.053 PMID: 25271843
41. Alexander AL, Lee JE, Lazar M, Field AS. Diffusion Tensor Imaging of the Brain. 2007; 4(July):316-29. https://doi.org/10.1016/j.nurt.2007.05.011 PMID: 17599699
42. Pierpaoli C, Jones DK. Removing CSF Contamination in Brain DT-MRIs by Using a Two-Compartment Tensor Model. International Society for Magnetic Resonance in Medicine Meeting. 2004. p. 1215.
43. Wang Y, Gupta A, Liu Z, Zhang H, Escolar ML, Gilmore JH, et al. DTI registration in atlas based fiber analysis of infantile Krabbe disease. Neuroimage. 2011; 55:1577-86. https://doi.org/10.1016/j. neuroimage.2011.01.038 PMID: 21256236
44. Zhang H, Yushkevich P a, Alexander DC, Gee JC. Deformable registration of diffusion tensor MR images with explicit orientation optimization. Med Image Anal. 2006 Oct; 10(5):764-85. https://doi.org/ 10.1016/j.media.2006.06.004 PMID: 16899392
45. Zhang H, Yushkevich PA, Rueckert D, Gee JC. Unbiased white matter atlas construction using diffusion tensor images. Med Image Comput Comput Assist Interv. 2007; 10:211-8. PMID: 18044571
46. Mori S, Crain B, Chacko V, Van Ziji P. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol. 1999; 45(2):265-9. PMID: 9989633
47. Wang R, Benner T. Diffusion toolkit: a software package for diffusion imaging data processing and tractography. Proc Intl Soc Mag Reson ⋯ [Internet]. 2007 [cited 2014 Jul 5]; 15:3720.
48. Hoy AR, Kecskemeti SR, Alexander AL. Free water elimination diffusion tractography: A comparison with conventional and fluid-attenuated inversion recovery, diffusion tensor imaging acquisitions. J Magn Reson Imaging. 2015 Apr;1-10.
49. Gold BT, Zhu Z, Brown CA, Andersen AH, LaDu MJ, Tai L, et al. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. Neurobiol Aging [Internet]. 2014 Oct [cited 2015 May 8]; 35(10):2263-71. https://doi.org/10.1016/j.neurobiolaging.2014.04.030 PMID: 24866404
50. Huang H, Fan X, Weiner M, Martin-Cook K, Xiao G, Davis J, et al. Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization. Neurobiol Aging. 2012; 33:2029-45. https://doi.org/10.1016/j.neurobiolaging.2011.06.027 PMID: 21872362
51. Adluru N, Destiche DJ, Lu SY-F, Doran ST, Birdsill AC, Melah KE, et al. White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease. Neuro-Image Clin [Internet]. 2014; 4:730-42. https://doi.org/10.1016/j.nicl.2014.04.008 PMID: 24936424
52. Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain [Internet]. 2007 Jul [cited 2014 Feb 4]; 130(Pt 7):1767-76. https://doi.org/10.1093/brain/awm102 PMID: 17522104
53. Fellgiebel A, Schermuly I, Gerhard A, Keller I, Albrecht J, Weibrich C, et al. Functional relevant loss of long association fibre tracts integrity in early Alzheimer's disease. Neuropsychologia. 2008; 46:1698-706. https://doi.org/10.1016/j.neuropsychologia.2007.12.010 PMID: 18243252
54. Takahashi S, Yonezawa H, Takahashi J, Kudo M, Inoue T, Tohgi H. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett [Internet]. 2002; 332:45-8. PMID: 12377381
55. Hofer S, Frahm J. Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage. 2006 Sep; 32(3):989-94. https:// doi.org/10.1016/j.neuroimage.2006.05.044 PMID: 16854598
56. Okada T, Miki Y, Fushimi Y, Hanakawa T. Diffusion-Tensor Fiber Tractography: Intraindividual Comparison of 3.0-T and 1.5-T MR Imaging 1. Radiology. 2006; 238(2):668-78. https://doi.org/10.1148/radiol. 2382042192 PMID: 16396839
57. Wakana S, Jiang H, Nagae-Poetscher L, van Zijl P, Mori S. Fiber Tract-based Atlas of Human White Matter Anatomy1. Radiology [Internet]. 2004 [cited 2013 Dec 19]; 230(1):77-87. https://doi.org/10. 1148/radiol.2301021640 PMID: 14645885
58. Pajevic S, Pierpaoli C. Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brain. Magn Reson Med [Internet]. 2000 Jun; 43(6):921. PMID: 10861892
59. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B [Internet]. 1995; 57:289-300.
60. Makris N, Goldstein JM, Kennedy D, Hodge SM, Caviness VS, Faraone S V., et al. Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res. 2006; 83:155-71. https://doi. org/10.1016/j.schres.2005.11.020 PMID: 16448806
61. Frazier J a, Chiu S, Breeze JL, Makris N, Lange N, Kennedy DN, et al. Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry [Internet]. 2005 Jul; 162(7):1256-65. https://doi.org/10.1176/appi.ajp.162.7.1256 PMID: 15994707
62. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage [Internet]. 2006 Jul 1 [cited 2013 Dec 12]; 31(3):968-80. https://doi.org/10.1016/j. neuroimage.2006.01.021 PMID: 16530430
63. Goldstein JM, Seidman LJ, Makris N, Ahern T, O'Brien LM, Caviness VS, et al. Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biol Psychiatry [Internet]. 2007 Apr 15 [cited 2013 Dec 16]; 61(8):935-45. https://doi.org/10.1016/j.biopsych.2006.06.027 PMID: 17046727
64. Winkler AM, Ridgway GR, Webster M a, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage [Internet]. The Authors; 2014 May 15 [cited 2014 Jul 22]; 92:381-97. https:// doi.org/10.1016/j.neuroimage.2014.01.060 PMID: 24530839
65. Smith SM, Nichols TE. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009; 44:83-98. https://doi. org/10.1016/j.neuroimage.2008.03.061 PMID: 18501637
66. Li X, Westman E, Ståhlbom AK, Thordardottir S, Almkvist O, Blennow K, et al. White matter changes in familial Alzheimer's disease. J Intern Med [Internet]. 2015 Jan 31 [cited 2015 May 8];
67. Ryan N, Keihaninejad S, Shakespeare T, Lehmann M, Crutch S, Malone I, et al. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain. 2013; 136(5):1399-414.
68. Bendlin B, Ries M, Canu E, Sodhi A. White matter is altered with parental family history of Alzheimer's disease. Alzheimer's . . .. 2010; 6(5):394-403.
69. Lyall DM, Harris SE, Bastin ME, Muñoz Maniega S, Murray C, Lutz MW, et al. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936. Neurobiol Aging. 2014; 35.
70. Westlye LT, Reinvang I, Rootwelt H, Espeseth T. Effects of APOE on brain white matter microstructure in healthy adults. Neurology. 2012; 79:1961-9. https://doi.org/10.1212/WNL.0b013e3182735c9c PMID: 23100402
71. Berlot R, Metzler-Baddeley C, Jones DK, O'Sullivan MJ. CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment. Neuroimage [Internet]. The Authors; 2014 Feb 3 [cited 2014 Feb 11];1-9.
72. Maier-Hein KH, Westin CF, Shenton ME, Weiner MW, Raj A, Thomann P, et al. Widespread white matter degeneration preceding the onset of dementia. Alzheimer's Dement. 2015; 11:485-93.
73. Metzler-Baddeley C, Jones DK, Steventon J, Westacott L, Aggleton JP, O'Sullivan MJ. Cingulum microstructure predicts cognitive control in older age and mild cognitive impairment. J Neurosci [Internet]. 2012 Dec 5 [cited 2014 Aug 23]; 32(49):17612-9. https://doi.org/10.1523/JNEUROSCI.3299-12.2012 PMID: 23223284
74. Metzler-Baddeley C, Hunt S, Jones DK, Leemans A, Aggleton JP, O'Sullivan MJ. Temporal association tracts and the breakdown of episodic memory in mild cognitive impairment. Neurology. 2012; 79:2233-40. https://doi.org/10.1212/WNL.0b013e31827689e8 PMID: 23175726
75. Ray NJ, Metzler-Baddeley C, Khondoker MR, Grothe MJ, Teipel S, Wright P, et al. Cholinergic basal forebrain structure influences the reconfiguration of white matter connections to support residual memory in mild cognitive impairment. J Neurosci. 2015; 35:739-47. https://doi.org/10.1523/JNEUROSCI. 3617-14.2015 PMID: 25589767
76. Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn Reson Med [Internet]. 2009 Sep [cited 2013 Sep 23]; 62(3):717-30. https://doi.org/10.1002/ mrm.22055 PMID: 19623619
77. van Bruggen T, Zhang H, Pasternak O, Meinzer H-P, Stieltjes B, Fritzsche K. Free-water elimination for assessing microstructural gray matter pathology-with application to Alzheimer's Disease. International Society for Magnetic Resonance in Medicine Meeting. 22013. p. 790.
78. Assaf Y, Cohen Y. Non-mono-exponential attenuation of water and N-acetyl aspartate signals due to diffusion in brain tissue. J Magn Reson. 1998; 131:69-85. https://doi.org/10.1006/jmre.1997.1313 PMID: 9533908
79. Roher AE, Weiss N, Kokjohn TA, Kuo Y, Kalback W, Anthony J, et al. Articles Increased A Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer ' s Disease †. Biochemistry. 2002; 41(37):11080-90. PMID: 12220172
80. Roher AE, Maarouf CL, Malek-ahmadi M, Wilson J, Kokjohn TA, Daugs ID, et al. Subjects harboring presenilin familial Alzheimer ' s disease mutations exhibit diverse white matter biochemistry alterations. Am J Neurodegener Dis. 2013; 2(3):187-207. PMID: 24093083
81. Larsson EM, Englund E, Sjöbeck M, Lätt J, Brockstedt S. MRI with diffusion tensor imaging post-mortem at 3.0 T in a patient with frontotemporal dementia. Dementia and Geriatric Cognitive Disorders. 2004. p. 316-9. https://doi.org/10.1159/000077162 PMID: 15178944
82. Alexander AL, Hurley S a, Samsonov A a, Adluru N, Hosseinbor AP, Mossahebi P, et al. Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains. Brain Connect [Internet]. 2011 Jan [cited 2014 Aug 12]; 1(6):423-46. https://doi.org/10.1089/brain.2011.0071 PMID: 22432902
83. Alobuia WM, Xia W, Vohra BPS. Axon degeneration is key component of neuronal death in amyloid-β toxicity. Neurochem Int. 2013; 63:782-9. https://doi.org/10.1016/j.neuint.2013.08.013 PMID: 24083988
84. Christensen DZ, Huettenrauch M, Mitkovski M, Pradier L, Wirths O. Axonal degeneration in an alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal aβ accumulation. Front Aging Neurosci. 2014; 6.
85. Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol [Internet]. 2013; 9:25-34. https://doi.org/10.1038/nrneurol.2012.236 PMID: 23183882
86. Collins-Praino LE, Francis YI, Griffith EY, Wiegman AF, Urbach J, Lawton A, et al. Soluble amyloid beta levels are elevated in the white matter of Alzheimer¿s patients, independent of cortical plaque severity. Acta Neuropathol Commun [Internet]. 2014; 2(1):83.
87. Wolfe MS, Guenette SY. APP at a glance. J Cell Sci [Internet]. 2007; 120(18):3157-61.
88. Lansbury PT. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci U S A. 1999; 96(March):3342-4.